Accelerate Diagnostics, Inc. (AXDX) News

Accelerate Diagnostics, Inc. (AXDX): $0.86

0.09 (+11.56%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

Filter AXDX News Items

AXDX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest AXDX News From Around the Web

Below are the latest news stories about ACCELERATE DIAGNOSTICS INC that investors may wish to consider to help them evaluate AXDX as an investment opportunity.

Accelerate Diagnostics (AXDX) Expands in In Vitro Diagnostics

Accelerate Diagnostics' (AXDX) Arc system eliminates the need for overnight culture incubation, drastically reducing the wait time for identification results.

Yahoo | November 29, 2023

Bruker's (BRKR) New Collaboration to Use MALDI Biotyper System

Bruker (BRKR) and Accelerate Diagnostics are set to work together to bring rapid, automated microbial identification directly from positive blood culture samples.

Yahoo | November 28, 2023

Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the signing of a collaboration and quality agreement with Bruker Corporation (NASDAQ: BRKR), the provider of the market-leading MALDI Biotyper system for microbial identification. This agreement enables both companies to validate the use of Accelerate Diagnostics' Arc™ system, an innovative, automated positive blood culture sample preparation platform, with Bruker's MALDI Biotyper® s

Yahoo | November 27, 2023

Accelerate Diagnostics (AXDX) Loses -25.65% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Accelerate Diagnostics (AXDX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Yahoo | November 22, 2023

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q3 2023 Earnings Call Transcript

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q3 2023 Earnings Call Transcript November 9, 2023 Accelerate Diagnostics, Inc. beats earnings expectations. Reported EPS is $0.14, expectations were $-0.94. Operator: Good day, and welcome to the Accelerate Diagnostics, Inc. 2023 Third Quarter Results Conference Call. All participant’s will be in listen-only mode. After today’s presentation, there will be a […]

Yahoo | November 11, 2023

Accelerate Diagnostics Reports Third Quarter 2023 Results

Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter ended September 30, 2023.

Yahoo | November 9, 2023

Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, November 9, 2023, at 4:30 p.m. Eastern Time to review 2023 third quarter results.

Yahoo | October 30, 2023

Accelerate Diagnostics (AXDX) Moves 12.7% Higher: Will This Strength Last?

Accelerate Diagnostics (AXDX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Yahoo | October 3, 2023

Insider Sell: CEO Jack Phillips Sells 733 Shares of Accelerate Diagnostics Inc

On September 13, 2023, Jack Phillips, the CEO of Accelerate Diagnostics Inc (NASDAQ:AXDX), sold 733 shares of the company.

Yahoo | September 15, 2023

Q2 2023 Accelerate Diagnostics Inc Earnings Call

Q2 2023 Accelerate Diagnostics Inc Earnings Call

Yahoo | August 11, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!